1. PO-1023 Impact of 18F-FDG-PET/CT in the management of suspected RAI refractory DTC persistence/recurrence. (August 2021) Authors: Lodi Rizzini, E.; Zanoni, L.; Tabacchi, E.; Repaci, A.; Scampoli, C.; Vallerossa, D.; Laghi, V.; Cavallini, L.; Razganiayeva, N.; Cardano, R.; Scirocco, E.; Cammelli, S.; Frezza, G.P.; Morganti, A.G.; Fanti, S.; Monari, F. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S851 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-1027 Radioiodine therapy guided by 124I-PET/CT in metastatic DTC: long-term follow-up data. (August 2021) Authors: Lodi Rizzini, E.; Allegri, V.; Zanoni, L.; Tabacchi, E.; Laghi, V.; Strigari, L.; Repaci, A.; Scampoli, C.; Vallerossa, D.; Deraco, E.; Cavallini, L.; Bertini, F.; Cammelli, S.; Frezza, G.P.; Morganti, A.G.; Fanti, S.; Monari, F. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗